(Q42274882)

19 October 2017

Depressed hepatic dihydropyrimidine dehydrogenase activity and fluorouracil-related toxicities (English)

1 reference

19 October 2017

Stéphan F

1

1 reference

19 October 2017

Etienne MC

2

1 reference

19 October 2017

Wallays C

3

1 reference

19 October 2017

Milano G

4

1 reference

19 October 2017

Clergue F

5

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

American Journal of Medicine

19 October 2017

1 reference

19 October 2017

99

1 reference

19 October 2017

685-688

1 reference

19 October 2017

6

1 reference

Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity

19 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980259-9

Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980259-9

Fatal acute tumor lysis syndrome with metastatic breast carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980259-9

Tumor lysis syndrome in nonhematopoietic neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980259-9

Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980259-9

Population study of dihydropyrimidine dehydrogenase in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980259-9

A New Syndrome: Ascites, Hyperbilirubinemia, and Hypoalbuminemia after Biochemical Modulation of Fluorouracil with N-Phosphonacetyl-L-Aspartate (PALA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980259-9

Clearance of continuously infused 5-fluorouracil in adults having lung or gastrointestinal carcinoma with or without hepatic metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980259-9

The metabolism of uracil-2-14C and the granulocyte response to endotoxin as indicators of the toxicity produced in patients receiving 5-fluorouracil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980259-9

10.1016/S0002-9343(99)80259-9

7 January 2021

Identifiers

DOI

1 reference

19 October 2017

1 reference